Literature DB >> 27664584

microRNAs target SRSF7 splicing factor to modulate the expression of osteopontin splice variants in renal cancer cells.

Joanna Boguslawska1, Elzbieta Sokol2, Beata Rybicka2, Alicja Czubaty3, Katarzyna Rodzik2, Agnieszka Piekielko-Witkowska4.   

Abstract

SRSF7 is a SR splicing factor involved in the regulation of splicing and mRNA export of cancer-related genes. The mechanisms regulating the expression of SRSF7 are unknown. This study shows that SRSF7 expression in cancer cells is regulated by microRNAs: short, non-coding RNAs that bind to 3'UTR of target genes and downregulate their expression. We show that microRNAs miR-30a-5p and miR-181a-5p together with SRSF7 form regulatory feedback loop in which the expression of microRNAs is recurrently regulated by its target. Finally, we demonstrate that silencing of SRSF7 affects the expression of osteopontin splice variants and decreases proliferation rate of renal cancer cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Osteopontin; Renal cancer; SPP1; SRSF7; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27664584     DOI: 10.1016/j.gene.2016.09.031

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

Review 1.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

Review 2.  The distinct roles of zinc finger CCHC-type (ZCCHC) superfamily proteins in the regulation of RNA metabolism.

Authors:  Yishu Wang; Yu Yu; Yidan Pang; Haojun Yu; Wenqi Zhang; Xian Zhao; Jianxiu Yu
Journal:  RNA Biol       Date:  2021-05-04       Impact factor: 4.652

Review 3.  Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment.

Authors:  Anthony J Murphy; Alex H Li; Peichao Li; Hong Sun
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

4.  The co-expression networks of differentially expressed RBPs with TFs and LncRNAs related to clinical TNM stages of cancers.

Authors:  Shuaibin Lian; Liansheng Li; Yongjie Zhou; Zixiao Liu; Lei Wang
Journal:  PeerJ       Date:  2019-09-17       Impact factor: 2.984

5.  SRSF7 maintains its homeostasis through the expression of Split-ORFs and nuclear body assembly.

Authors:  Vanessa Königs; Camila de Oliveira Freitas Machado; Benjamin Arnold; Nicole Blümel; Anfisa Solovyeva; Sinah Löbbert; Michal Schafranek; Igor Ruiz De Los Mozos; Ilka Wittig; Francois McNicoll; Marcel H Schulz; Michaela Müller-McNicoll
Journal:  Nat Struct Mol Biol       Date:  2020-03-02       Impact factor: 15.369

Review 6.  Noncoding RNAs regulate alternative splicing in Cancer.

Authors:  Yunze Liu; Xin Liu; Changwei Lin; Xianhong Jia; Hongmei Zhu; Jun Song; Yi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-01-06

7.  Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.

Authors:  Galina Yurevna Zheleznyakova; Eliane Piket; Maria Needhamsen; Michael Hagemann-Jensen; Diana Ekman; Yanan Han; Tojo James; Mohsen Khademi; Faiez Al Nimer; Patrick Scicluna; Jesse Huang; Ingrid Kockum; Omid R Faridani; Tomas Olsson; Fredrik Piehl; Maja Jagodic
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

8.  Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma.

Authors:  Tingting Jia; Fengze Wang; Bo Qiao; Yipeng Ren; Lejun Xing; Haizhong Zhang; Hongbo Li
Journal:  Front Mol Biosci       Date:  2021-03-26

Review 9.  Emerging roles of spliceosome in cancer and immunity.

Authors:  Hui Yang; Bruce Beutler; Duanwu Zhang
Journal:  Protein Cell       Date:  2021-07-01       Impact factor: 15.328

10.  SMDB: pivotal somatic sequence alterations reprogramming regulatory cascades.

Authors:  Limin Jiang; Mingrui Duan; Fei Guo; Jijun Tang; Olufunmilola Oybamiji; Hui Yu; Scott Ness; Ying-Yong Zhao; Peng Mao; Yan Guo
Journal:  NAR Cancer       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.